Systematic reaction to electrolytic treatment of pig livers in vivo

ANZ Journal of Surgery

Volumn 74, Issue 7, 2004, Pages 586-590

  Berry, David ^a   Garcea, Giuseppe ^a,c   Chong, Chillton ^b   Silman, Eric ^b   Finch, Guy ^a   Dennison, Ashley ^a   Maddern, Guy J ^b  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Electrolysis; Interleukin 8; Systemic reaction; Tumour necrosis factor

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BIOCHEMICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; INTERLEUKIN 8; LIVER ENZYME; TUMOR NECROSIS FACTOR ALPHA;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE LEAKAGE; BLOOD SAMPLING; CONTROLLED STUDY; ELECTROLYSIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; LIVER; LIVER FUNCTION; LIVER LEVEL; NONHUMAN; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; RISK; SWINE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; BIOLOGICAL MARKERS; ELECTROLYSIS; ELECTROSURGERY; FEMALE; INFLAMMATION; INTERLEUKIN-8; LIVER; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3442888323     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2004.02986.x     Document Type: Article

References (41)

1. Boring CC, Squires TS, Tong MS. Cancer statistics. CA Cancer J. Clin. 1994; 44: 7-26.
2. Goeghegan JG, Scheele J. Treatment of colorectal liver metastases. Br. J. Surg. 1999; 86: 159-69.
3. Simmonds PC. Palliative chemotherapy for advanced colorectal cancer. BMJ 2000; 321: 521-2.
4. Stangl R, Altendorf-Hoffman A, Charnley RM. Factors influencing the natural history of colorectal liver metastases. Lancet 1994; 343: 1405-10.
5. August DA, Sugarbaker PH, Ottow RT. Hepatic resection of colorectal metastases. Ann. Surg. 1985; 201: 210-18.
6. Scheele JC, Stangl R, Altendorf-Hoffman A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991; 110: 13-29.
7. Scheele J, Stang R, Altendorf-Hoffman A, Paul M. Resection of colorectal liver metastases. World J. Surg. 1995; 19: 51-71.
8. Wong SL, Edwards MJ, Chao C, Simpson D, McMasters KM. Radiofrequency ablation for unresectable hepatic tumours. Am. J. Surg. 2001; 182: 552-7.
9. Suguira N, Takara K, Ohio M. Treatment of small hepatocellular carcinoma by percutaneous injection of ethanol into the tumour with real-time ultrasound scanning. Acta Hepatol. Jap. 1983; 24: 920-1.
10. Ohnishi K. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepato-Gastroenterol. 1998; 45: 1254-8.
11. Honda N, Guo Q, Uchida H, Ohishi H, Hiasa U. Percutaneous hot saline injection therapy for hepatic tumours: an alternative to percutaneous ethanol injection therapy. Radiologia 1994; 190: 53-7.
12. Seki T, Wakabayashi M, Nakagawu T et al. Percutaneous microwave coagulation therapy for solitary metastatic liver tumours from colorectal cancer: a pilot clinical study. Am. J. Gastroenterol 1999; 94: 322-7.
13. Kopecky K, Yang R, Snagvi N, Rescoria F. Liver tumour ablation with high-intensity focused ultrasound. Semin Interv Radiol. 1993; 10: 125-31.
14. Germer C, Albrecht D, Roggan A, Isbert C, Buhr HJ. Experimental study of laparoscopic laser-induced thermotherapy for liver tumours. Br. J. Surg. 1997; 84: 317-20.
15. Gruenberger T, Jourdan JL, Zhao J, King J, Morris DL. Reduction in recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases. Arch. Surg. 2001; 136: 1154-7.
16. Taylor I. Colorectal liver metastases-to treat or not to treat. Br. J. Surg. 1985; 72: 511-16.
17. Taylor I. A critical review of the treatment of colorectal liver metastases. Clin. Oncol. 1982; 10: 169-73.
18. Dennison AR, Baer HU, Blumgart LH. The management of secondary liver tumours. Surgery 1992; 10: 169-73.
19. Washington K, Debelak JP, Gobell C et al. Hepatic cryoablation-induced lung injury: Histopathological findings. J. Surg. Res. 2001; 95: 1-7.
20. Bagia JS, Perera DS, Morris DL. Renal impairment in hepatic cryotherapy. Cryobiology 1998; 36: 263-7.
21. Seifert JK, Stewart GJ, Hewitt PM, Boltan EJ, Junginger T, Morris DL. Interleukin-6 and tumour necrosis facto-alpha levels following hepatic cryotherapy. Association with volume and duration of freezing. World J. Surg. 1999; 23: 1019-26.
22. Primrose JN. Treatment of colorectal liver metastases: surgery cryotherapy or radiofrequency ablation. Gut 2002; 50: 1-5.
23. Ksontini R, MacKay S, Moldawer LL. Revisiting the role of tumour necrosis factor alpha and the response to surgical injury and inflammation. Arch. Surg. 1998; 133: 558-67.
24. Bone R. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit. Care Med. 1996; 24: 163-72.
25. Christiman JW, Holden EP, Blackwell TS. Strategies of blocking the systemic effects of cytokines in the sepsis syndrome. Crit. Care Med. 1995; 23: 955-63.
26. Colletti L, Kunkel S, Walz A, Burdick M, Kunkel R, Wilke C. Chemokine expression during hepatic Ischaemia/reperfusion-induced lung injury in the rat. J. Clin. Invest. 1995; 95: 134-41.
27. Carrick J, Martins O, Snider C et al. The effect of LPS on cytokine synthesis and lung neutrophil influx after hepatic ischaemia/reperfusion injury in the rat. J. Surg. Res. 1997; 68: 16-23.
28. Robertson GSM, Wemyss-Holden S, Dennison AR et al. Experimental study of electrolysis-induced hepatic necrosis. Br. J. Surg. 1998; 85: 1212-16.
29. Michie HR, Manogue KR, Spirggs DR. Detection of circulating tumour necrosis factor after endotoxin administration. N. Engl. J. Med. 1988; 318: 1481-6.
30. Cannon JG, Tompkins RG, Gelfand JA, Tompkins RG, Burke JF, Dinaerello CA. Circulating interleukin-1 and tumour necrosis factor in septic shock and experimental endotoxin fever. J. Infect Dis. 1990; 161: 79-4.
31. Cannon JG, Tompkins RG, Gelfand JA, Tompkins RG, Burke JF, Dinaerello CA. Circulating interleukin-1 beta and tumour necrosis facto-alpha after burn injury in humans. Crit. Care Med. 1992; 20: 1414-19.
32. Tracey KJ, Beutler B, Lowry J et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470-4.
33. Colletti LM, Kunkel SL, Walz A et al. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat: the role of Epithelial neutrophil Activating Protein. J. Clin. Invest. 1995; 95: 134-41.
34. Schuder G, Pistorius G, Schneider G, Feifel G. Short note: preliminary experience with percutaneous cryotherapy of liver tumours. Br. J. Surg. 1998; 85: 1210-11.
35. Berendson J, Simonsson D. Electrochemical aspects of treatment of tissue with direct current. Eur. J. Surg. Suppl. 1994; 574: 111-15.
36. Nordenstrom BE. Survey of mechanisms in electrochemical treatment (ECT) of cancer. Eur. J. Surg. Suppl. 1994; 574: 93-109.
37. Nordenstrom B. Biologically closed electrical circuits: Activation of vascular interstitial closed electric circuits for treatment of inoperable cancers. J. Bioelectricity 1984; 3: 137-53.
38. Wemyss-Holden SA, Dennison AR, Finch GJ, de la Hall M, Maddern GJ. Electrolytic ablation as an adjunct to liver resection: experimental studies of predictability and safety. Br. J. Surg. 2002; 89: 579-85.
39. Wood TF, Rose DN, Chung M. Radiofrequency ablation: a novel primary and adjunctive ablative technique for hepatic malignancies. Am. Surg. 2000; 65: 593-600.
40. Francica F, Marone G, Solbiati L. Haemobilia, intrahepatic haematoma and acute thrombosis with cavernomatous transformation of the portal vein after percutaneous thermoblation of a liver metastasis. Eur. Radiol. 2000; 10: 926-9.
41. DeBaere T, Elias D, Dromain C. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am. J. Roentgenol. 2000; 175: 303-6.